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ABSTRACT 
Objective: The main objective of the research work was to fabricate sacran hydrogel film containing keratinocyte growth factor (Sacran/KGF-HGF), 
and to evaluate their wound healing ability in alloxan-induced diabetic mice model. 
Methods: The physicochemical characterization of Sacran/KGF-HGF were investigated by thickness, tensile strength, swelling ratio, x-ray 
diffractometer (XRD), scanning electron microscope (SEM), and biodegradability. The wound healing ability was investigated by creating two full-
thickness excisional wounds inalloxan-induced diabetic mice.  
Results: The thickness, tensile strength, and swelling ratio results showed that KGF in the Sacran/KGF-HGF improved not only the thickness of 
sacran hydrogel film (Sacran-HGF), but also the tensile strength and swelling ability of Sacran-HGF. The XRD and SEM results confirmed that the 
Sacran/KGF-HGF were amorphous and similar morphology to Sacran-HGF, respectively. The biodegradability results revealed that the 
Sacran/KGF-HGF degraded for about 41.29% in trichloroacetic acid (TCA) and 22.92% in TrypLE™ (recombinant enzyme) solutions. In addition, 
KGF improved the degradability of Sacran/KGF-HGF in both solutions. Interestingly, the Sacran/KGF-HGF, which was applied on wound site, 
considerably improved the wound healing ability of Sacran-HGF at 6, 9 and 12 d in alloxan-induced diabetic mice model, compared to control 
(non-treated).  
Conclusion: These results suggest that KGF has the potential to promote the chronic wound healing ability of Sacran-HGF. 
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The skin, a layered organ, covers the entire human body with the 
main function as a protector for preventing skin dehydration and 
microorganism’s penetration from outside the body. If the skin is 
injured, it provides complex natural biological reactions and 
complicated wound healing processes [1]. The wound healing 
process basically consists of several stages, namely hemostasis, 
inflammation, proliferation, vascularization, production and 
restoration of the extracellular matrix (ECM)[2]. However, the 
healing process in chronic wounds, especially in diabetic condition, 
will be disrupted with persistent inflammation, slow migration of 
keratinocytes and fibroblast, abnormal regulation of chemokines 
and production of growth factor, the irregular response of 
inflammatory cells, and inhibition of angiogenesis [3–5]. Recently, a 
number of studies using new therapy for diabetic wound infections 
were investigated [6, 7]. Regenerative therapy using growth factors 
can be used to accelerate the chronic wounds healing [8, 9]. One of 
the essential growth factors for impaired healing therapy is 
Keratinocyte Growth Factor (KGF). KGF is a major cellular 
component of the epidermis, not only important for the maintenance 
of the barrier, but also for the restoration of the wound through a 
process known as epithelization [10]. KGF also acts specifically on 
epithelial cells and stimulates cell proliferation and migration [11]. 
Nowadays, the concept of wound healing by maintaining a moist 
environment at the wound site has been established as a standard 
therapy for chronic wounds [12, 13]. The moist wound 
environments can accelerate the wound healing process by enhance 
re-epithelization, stimulate collagen synthesis, increase growth 
factor activity, and accelerate the healing process [14]. 
Recently, the modern wound dressings have been developed to 
preserve and protect a moist environment in the both acute and 
chronic wounds [15]. The dressings are available in the forms of 
films, foam, hydrogel and hydrocolloids, which can be incorporated 
with a bioactive agent to promote wound healing [16]. Among other 
forms, the thin hydrogel films (HGFs) consisting of water-swollen 
polymer networks have attracted a lot of attention for the last few 
decades due to their excellent properties such as adhesive, porous, 
semi-permeable, flexible and easily conformable, for the treatment 
of acute and chronic wounds [17]. 
During last two decades, natural polymers are widely used in the 
regenerative medicine field, outstandingly for wounds dressing 
because of their biocompatibility, biodegradability and similarity to 
the extracellular matrix [18]. Natural polymers are involved in the 
repair of damaged tissues and consequently in skin regeneration, 
inducing and stimulating the wound healing process [19]. In 
addition, the swollen ability of natural polymer-based hydrogels has 
some functions to absorb the overage of wound exudate and 
accelerate autolysis process for wound debridement [20]. 
Sacran, a giant molecular polysaccharide, was newly isolated 
from cyanobacterium Aphanothece sacrum. Sacran has the 
unique properties to be developed as a new biomaterial in HGFs 
for wound dressing application, such as a very high molecular 
weight (2.9 × 107Da), a safe biomaterial and a high moisturizing 
effect [21]. In the previous study, we successfully developed a 
physically crosslinked Sacran-HGF and revealed its potential as a 
novel wound dressing material [22]. Furthermore, we confirmed 
that Sacran-HGF has the potential to deliver water-soluble 
complex of curcumin and 2-hydroxypropyl-γ-cyclodextrin at the 
wound site and promote the acute wound healing ability [23, 
24]. Until now, there is no study regarding the combination of 
KGF with sacran HGF (Sacran/KGF-HGF) for chronic wound 
therapy. Therefore, we fabricated Sacran/KGF-HGF, then 
evaluated their physicochemical properties and wound healing 
ability in diabetic mice model. 
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MATERIALS AND METHODS 
Materials 
The sacran was kindly provided by Green Science Material 
(Kumamoto, Japan). Keratonicyte growth factor (KGF) was 
purchased from Skin Actives Scientific (Arizona, USA). 
Trichloroacetic acid (TCA) and TrypLE™ (recombinant enzyme) 
were bought from Wako Chemical (Tokyo, Japan). All the reagents 
were analytical grade and used without further purification. 
Preparation of sacran/KGF-HGF 
The preparation method of the Sacran-HGF was briefly described in 
our previous study using a solvent evaporation method[22]. The 
Sacran-HGF (1 × 1 cm2) was placed in Tissue-TekCryomold® (Sakura 
Finetek, Tokyo, Japan). Then, 10μL of KGFs (100 ng) in ammonium 
sulfate solution were placed and casted on the surface of the Sacran-
HGF. The Sacran-HGF was swollen for 24 h at 4 °C with light 
protection and dried for 4 h at 37 °C to obtain the Sacran/KGF-HGFs. 
Thickness test of sacran/KGF-HGF 
A dial thickness gauge (Teclock Corp., Nagano, Japan) was used to 
measure the thickness of Sacran-HGFs. 
Tensile strength of sacran/KGF-HGF 
The sacran/KGF-HGFs were clipped with 2 holding grips and pulled 
by the top clip at a rate of 0.5 mm/s in Textechnofavigraph 
(Moenchengladbach, Germany). Tensile strength was measured 
from the breakpoint of the HGFs for 3 times, then, the average value 





(p = breakpoint, b = width, d = thickness) 
Swollen ratio of sacran/KGF-HGF 
The sacran/KGF-HGFs (1 x 1 cm2) were immersed in PBS (pH 7.4) 
for 24 h and weighted (Wt) at room temperature. The gravimetric 
method was used to determine a swollen ratio of the sacran/KGF-
HGFs[25]. It was measured by comparing Wt and initial weight (Wo), 





Scanning electron microscopy analysis 
The sacran/KGF-HGFs were coated with gold for 10 s using the JFC-
1200 Fine Coater (JEOL, Tokyo, Japan). The surface of the HGFs was 
analyzed using scanning electron microscopy (SEM) with a JSM-
6510LA (JEOL, Tokyo, Japan) in 5 µl (x3000).  
X-ray diffractometric analysis 
The x-ray diffraction (XRD) patterns were acquired by a Powder X-
ray diffractometer (Rigaku Ultima IV, Tokyo, Japan). Briefly, the 
Sacran/KGF-HGFs were kept on a sample holder. The XRD settings 
were as follows: a Ni-filtered Cu-Kα radiation, the voltage of 40 kV, a 
current of 20 mA, divergent slit of 10 mm (0.5 °), a scanning speed of 
5 °/min, opened scattering and receiving slits.  
Biodegradability of sacran/KGF-HGF 
The sacran/KGF-HGFs (1 x 1 cm2) were weighed (Wo) and added 
with 2 ml TCA and TrypLE™ (20%) solutions for 24h. Then, HGFs 
were weighed as the final weight (Wt) and calculated the percent 
change in weight by the formula, Percent in Weight= 100-
(Wt/Wo*100). 
Alloxan-induced diabetic mice 
Male albino mice (strain: BALB/c, age: 6-8 w, body weight: 30-35 g, 
source: laboratory of pharmacology, teaching hospital, Universitas 
Padjadjaran) were housed under standard conditions of control 
temperature and humidity (25 °C±1, 40%) and a light/dark cycle 
(12/12 h). Before diabetic induction by alloxan, the mice fasted for 8 
h. Alloxan monohydrate (186.9 mg/kg body weight) was injected by 
intraperitoneal injection. 1 h after induction, 5% of glucose solution 
was applied to the mice for 24 h, then, replaced by distilled water. 
The blood glucose level of mice was measured using glucometer 
after 3 d of induction. Alloxan-induced diabetic mice had blood 
glucose levels at 150-250 mg/dl on the 3rd day after alloxan 
induction. 
Wound closure study of sacran/KGF-HGF 
The in vivo wound closure studies were performed as reported 
previous [22]. Briefly, two full-thickness excisional wounds were 
made on the dorsal side of hairless mice using 8-mm biopsy punch 
tools. Three mouse groups were prepared as Sacran-HGF, 
Sacran/KGF-HGFand control (without treatment). The HGFs were 
applied precisely on the wound site, after 6, 9 and 12 d, the wound 
areas were digitally photographed and quantified by Image J 
software. The wound sizes were expressed as a percentage of the 
respective initial wounds. All the animal research studies were 
approved by the Ethics Committee for Animal Care and Use of 
Kumamoto University (Ethical approval number: 25–203). 
Statistical analysis 
The quantitative data were expressed as the mean±standard error of 
the mean (SEM) while the statistical comparisons were made using 
the Scheffe's test. A p-value<0.05 was considered statistically 
significant. 
RESULTS AND DISCUSSION 
Preparation of sacran/KGF-HGF 
In the previous study, we successfully prepared a physically 
crosslinked Sacran-HGF using the solvent-evaporation method and 
considerably improved acute wound healing ability [22]. In this 
study, we next examined whether Sacran-HGFs can be formed in the 
presence of KGF for chronic wound therapy, and evaluated their 
physicochemical properties. Sacran/KGF-HGF was fabricated with 
the thickness of the film was higher then that of sacran-HGF (fig. 1a-
b). These results suggest that the KGF was effectively incorporated 
in the sacran-HGF. 
Physicochemical properties of sacran/KGF-HGF 
The HGFs need an excellent mechanical property for wound dressing 
application [27]. Therefore, we examined the tensile strength of 
sacran/KGF-HGF compared to sacran-HGF without KGF. The tensile 
strength of sacran/KGF-HGFs was determined from the breakpoint 
of the HGFs in the Textechnofavigraph apparatus. Fig. 1c showed 
that the addition of KGF in sacran-HGF significantly increased the 
tensile strength of sacran/KGF-HGF for 1.5 fold of Sacran-HGF (4 
Mpa), indicating that sacran/KGF-HGF stronger then that of sacran-
HGF.  
One of the ideal properties of the HGFs is a high swelling ability 
which is connected to the moisturizing effect of HGFs [28]. 
Therefore, we next evaluated the swelling ability of the sacran/KGF-
HGF. The gravimetric method was used to calculate the swelling 
ratio of the HGFs after immersing in PBS for 24 h, comparing to the 
initial weight. As shown in fig. 1d, the sacran/KGF-HGF was swollen 
about 12-fold compared to the initial weight. Meanwhile, sacran-
HGF was swollen about 10-fold compared to the initial weight. In the 
previous study, the dried film of cross-linked hyaluronic acid 
hydrogel films swelled sevenfold in volume [29]. These results 
suggest that the sacran/KGF-HGF improved the swelling ability of 
sacran-HGF and it is higher then that of cross-linked hyaluronic acid 
hydrogel films. 
To understand the morphology of the sacran/KGF-HGF, we 
investigated the HGFs by SEM. The surface of the HGFs was analyzed 
in 5 µl (x3000). It can be seen in fig. 2, the appearances of KGF could 
not be detected on the surface of Sacran-HGF, suggesting the KGF 
penetrate inside the HGFs. Further investigation is needed to clarify 
these findings. 
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Fig. 1: Physicochemical properties of sacran/KGF-HGF (a) Appearances (b) Thickness (c) Tensile strength (d) Swelling ratio. Each value 
represents the mean±S. E. of 3 experiments. *p<0.05 compared to sacran-HGF 
 
 
Fig. 2: Scanning electron microscopy analysis of sacran/KGF-HGF, an amorphous HGFs is important due to a high thermodynamic system 
and a high solubility [24]. To clarify the amorphous form in the sacran/KGF-HGF, we used an x-ray diffractometer. The results showed 
that the sacran/KGF-HGF had hallow pattern as same as sacran-HGF, indicating a high thermodynamic activities (fig. 3) 
 
 
Fig. 3: X-Ray diffractometer pattern of sacran/KGF-HGF 
 
Biodegradability of sacran/KGF-HGF 
HGFs for wound dressing application should be biodegradable and 
presents a suitable environment for the tissue repair [30, 31]. 
Therefore, we next evaluated the biodegradability of sacran/KGF-
HGF in chemical reagent (TCA) and enzyme (TrypLE™) solutions. 
Fig. 4 showed that sacran/KGF-HGF degraded for about 41.29% in 
TCA and 22.92% in the enzyme. In addition, KGF improved the 
degradability of sacran/KGF-HGF in both solutions. These results 
suggest that KGF has a synergistic effect with Sacran-HGF for 
biodegradability of HGF. 
 
 
Fig. 4: Biodegradability of sacran/KGF-HGF. Each value 
represents the mean±SE of 3 experiments. *p<0.05 compared to 
sacran-HGF in TCA 
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Wound closure study 
Finally, to clarify the effect of KGF in sacran-HGF for chronic wound 
healing, we created an alloxan-induced diabetic model for wound 
closure study. A higher dose of alloxan (180 mg/kg body weight) in 
mice can be used to create severe atrophy of pancreatic islets and 
induced pancreatic β cell apoptosis [32]. We prepared three mouse 
groups of sacran-HGF, Sacran/KGF-HGF and control (without 
treatment). Then, the HGFs were applied precisely on the wound site 
at 0 d. After 6, 9 and 12 d, the wound areas were digitally 
photographed and quantified by Image J software (fig. 5a-b). The 
sacran/KGF-HGF significantly accelerated the wound healing ability 
of sacran-HGF at 6, 9 and 12 d, indicating there is a positive effect 
between KGF and sacran-HGF in wound healing ability. Jimenej and 
Rampy confirmed that treatment of KGF resulted in an improvement 
in incisional wound healing due to an increase in breaking strength, 
collagen content, and epidermal thickness [33]. In addition, our 
previous study revealed that sacran-HGF increased wound healing 
ability, probably due to not only the moisturing effect but also the 
anti-inflammatory effect of sacran [22]. 
  
 
Fig. 5: Wound healing of sacran/KGF-HGF (a) Appearances (b) Wound Closure. Each value represents the mean±S. E. of 3 experiments. 
*p<0.05 compared to control 
 
CONCLUSION 
In this study, we successfully fabricated sacran/KGF-HGF for chronic 
wound healing with excellent physicochemical properties. The 
existence of KGF in sacran-HGF improved the thickness, swelling 
ability, and tensile strength of sacran-HGF. In addition, sacran/KGF-
HGF had an amorphous form and similar morphology to sacran-HGF. 
Moreover, KGF improved the degradability of sacran/KGF-HGF. 
Importantly, the sacran/KGF-HGF significantly accelerated the wound 
healing ability of sacran-HGF at 6, 9 and 12 d in alloxan-induced 
diabetic mice. These results suggest that KGF has the potential to 
promote the chronic wound healing ability of sacran-HGF. 
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